Melflufen and dex with bortezomib/daratumumab for myeloma: OP-104 study
Enrique Ocio • 1 Dec 2018
Effective immunomodulation with pomalidomide during induction TST for AML and MDS
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.